Nav: Home

ASU multi-million program to develop an automated, high-throughput radiological test

June 15, 2016

Arizona State University's Biodesign Institute announced today it is entering a new, $7M phase of a multi-million, multi-institutional development project to produce a diagnostic test to measure an individual's level of absorbed radiation in the event of an unplanned radiological or nuclear event.

Currently, there is no U.S. Food and Drug Administration cleared or approved, high-throughput system to measure the radiation dose absorbed by individuals within a large population. The ASU Radiation Biodosimetry System (ARad©), developed in collaboration with Thermo Fisher Scientific, is a real-time quantitative PCR-based (polymerase chain reaction), multi-gene panel designed to estimate absorbed radiation. The project is entering the verification phase with the goal of seeking clearance from the U.S. FDA.

"We are extremely proud to be moving forward into the device verification phase and planning validation studies needed for FDA submission. These efforts combine ASU's development of radiation biomarkers, automation and software for estimating an individual's absorbed dose with Thermo Fisher's expertise in the product commercialization process," said Joshua LaBaer, director of the Biodesign Institute's Virginia G. Piper Center for Personalized Diagnostics. "Our research team's ultimate goal is to translate our discoveries into an automated high-throughput diagnostic system for radiation biodosimetry that is capable of processing a high volume of blood samples per day."

The project is part of a potential $34.7 million in total funds authorized by the Biomedical Advanced Research and Development Authority (BARDA), a federal agency within the Office of the Assistant Secretary for Preparedness and Response of the U.S. Department of Health and Human Services. The assay utilizes the Applied Biosystems brand of qPCR Dx instruments for gene expression analysis.

"Thermo Fisher and its long heritage of providing leading qPCR technologies for molecular detection is uniquely suited to drive the ARad Biodosimetry Project with ASU," said Mark Smedley, president of Genetic Sciences at Thermo Fisher. "We are looking forward to continuing our partnership and enabling the next phase of this important work, which represents a novel approach to protect public safety."

"A critical part of the success of this project are the medical clinics and numerous volunteers that have provided blood samples to enable development of this medical device, many of whom are undergoing radiotherapy procedures," said Kristin Gillis, senior scientific project manager of the ARad Radiation Biodosimetry Project.

Collaborators to the team include: Dr. Joshua LaBaer, Director of the ASU Biodesign Institute and of the institute's Virginia G. Piper Center for Personalized Diagnostics; Sally Amundson, Professor of Radiation Oncology at Columbia's Center for Radiological Research; and Principal Investigators at City of Hope, Stanford University and Mayo Clinic, providing critical access to patient clinical samples.
This project has been funded in whole or in part with Federal funds from the Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services, under Contract No. HHS0100201000008C.

Media contact:

Joe Caspermeyer, (480) 727-0369;

About the Biodesign Institute at Arizona State University

The Biodesign Institute addresses today's critical global challenges in health care, sustainability and security by developing solutions inspired from natural systems and translating those solutions into commercially viable products and clinical practices.

About the U.S. DHHS Biomedical Advanced Research and Development Authority (BARDA)

BARDA, within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, uses a comprehensive portfolio approach to the advanced research and development, stockpile acquisition, innovation, and manufacturing infrastructure building of the necessary vaccines, drugs, therapeutics, diagnostic tools, and non-pharmaceutical products for public health medical emergencies including chemical, biological, radiological and nuclear threats, as well as pandemic influenza, and emerging infectious diseases.

Arizona State University

Related Blood Samples Articles:

Better, cheaper healthcare with dry blood samples
A drop of blood on filter paper, allowed to dry and stored for future diagnostic purposes -- considerably easier than the present-day, resource-consuming method using frozen blood samples in plastic tubes.
Rock samples indicate water is key ingredient for crust formation
By examining the cooling rate of rocks that formed more than 10 miles beneath the Earth's surface, scientists led by The University of Texas at Austin Jackson School of Geosciences have found that water probably penetrates deep into the crust and upper mantle at mid-ocean spreading zones, the places where new crust is made.
Method to identify bacteria in blood samples works in hours instead of days
Engineers at the University of California San Diego have developed a desktop diagnosis tool that detects the presence of harmful bacteria in a blood sample in a matter of hours instead of days.
New national Lyme Disease Biobank to accelerate research by making samples available
Bay Area Lyme Foundation, a national organization funding research to make Lyme disease easy to diagnose and simple to cure, announces the launch of the Lyme Disease Biobank, which is the first program to provide researchers with blood and urine samples from people with acute Lyme disease from multiple regions across the country, including the East Coast, West Coast and Upper Midwest.
New tool enables viewing spectrum from specific structures within samples
Fluorescence is an incredibly useful tool for experimental biology and it just got easier to tap into, thanks to the work of a group of University of Chicago researchers.
eDNA in seawater samples could reveal status of deepwater fish populations
Environmental DNA in seawater samples may provide accurate information about deepwater fish populations, according to a study published Nov.
Tumor cells in blood samples could predict prostate cancer spread
Researchers have found a group of circulating tumour cells in prostate cancer patient blood samples which are linked to the spread of the disease, according to new research* presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.
Researchers discover extensive mislabeling of gene expression samples
At least 1 in 3 gene expression studies contain mislabeled samples, according to a new study published in F1000Research.
Parkinson's disease biomarker found in patient urine samples
UAB researchers have found that stored samples of urine and cerebral-spinal fluid from patients with Parkinson's disease hold a brand-new type of biomarker -- a phosphorylated protein that correlates with the presence and severity of Parkinson's disease.
Rapid retrieval of live, infectious pathogens from clinical samples
A team lead by Donald Ingber, M.D., Ph.D., at the Wyss Institute for Biologically Inspired Engineering at Harvard University now reports a method in PLoS, which enables the rapid isolation and concentration of infectious bacteria from complex clinical samples to help speed up bacterial identification, and it should be able to accelerate the determination of antibiotic susceptibilities as well.

Related Blood Samples Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...